 This is a dedicated price action analysis of CRISPR stock. We highlight why investors should consider cutting exposure as CRSP formed another bull trap in June, corroborating its bearish bias. Investors should note that we have not observed any significant bear traps that can help sustain its bottom. Therefore, we expect a potentially steeper fall ahead. 